BMS‐986122
A selective positive allosteric modulator of the M1 muscarinic acetylcholine receptor
BMS-986122 is a chemical compound that functions as a selective positive allosteric modulator (PAM) of the M1 muscarinic acetylcholine receptor. It is being researched for its potential therapeutic applications in the treatment of cognitive disorders such as Alzheimer's disease and schizophrenia.
Chemical Structure[edit | edit source]
BMS-986122 is characterized by its unique chemical structure, which allows it to selectively bind to the M1 muscarinic receptor. This selectivity is crucial for its function as a PAM, enhancing the receptor's response to the endogenous neurotransmitter acetylcholine.
Mechanism of Action[edit | edit source]
BMS-986122 acts as a positive allosteric modulator, meaning it binds to a site on the M1 muscarinic receptor that is distinct from the active site. This binding enhances the receptor's response to acetylcholine without directly activating the receptor itself. By modulating the receptor's activity, BMS-986122 can potentially improve cognitive function by enhancing cholinergic signaling in the brain.
Therapeutic Potential[edit | edit source]
The M1 muscarinic receptor is implicated in various cognitive processes, and its modulation is considered a promising strategy for treating cognitive deficits associated with neurological disorders. BMS-986122, by selectively modulating this receptor, holds potential for improving symptoms in conditions such as Alzheimer's disease and schizophrenia, where cholinergic deficits are observed.
Research and Development[edit | edit source]
BMS-986122 is currently under investigation in preclinical and clinical studies to evaluate its efficacy and safety profile. The compound's ability to enhance cognitive function without the side effects associated with direct agonists of the muscarinic receptors makes it a promising candidate for further development.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
